202 related articles for article (PubMed ID: 6442777)
1. [Molecular bases of lipidoses].
Tamai Y
Tanpakushitsu Kakusan Koso; 1984 Dec; 29(14):1735-58. PubMed ID: 6442777
[No Abstract] [Full Text] [Related]
2. The biochemistry of sphingolipid storage diseases.
Sandhoff K
Angew Chem Int Ed Engl; 1977 May; 16(5):273-85. PubMed ID: 406814
[No Abstract] [Full Text] [Related]
3. Inherited neuropathies related to disorders of lipid metabolism.
Thomas PK
Adv Neurol; 1988; 48():133-44. PubMed ID: 2446477
[No Abstract] [Full Text] [Related]
4. [Recent advances in sphingolipidosis research].
Tamai Y; Kojima H
Tanpakushitsu Kakusan Koso; 1990 May; 35(7 Suppl):1291-303. PubMed ID: 1972585
[No Abstract] [Full Text] [Related]
5. Enzymatic abnormalities in diseases of sphingolipid metabolism.
Brady RO
Clin Chem; 1967 Jul; 13(7):565-77. PubMed ID: 5006481
[No Abstract] [Full Text] [Related]
6. Enzymatic diagnosis of sphingolipidoses.
Suzuki K
Methods Enzymol; 1987; 138():727-62. PubMed ID: 2885713
[No Abstract] [Full Text] [Related]
7. Progress in investigations of sphingolipidoses.
Adachi M; Schneck L; Volk BW
Acta Neuropathol; 1978 Aug; 43(1-2):1-18. PubMed ID: 97916
[No Abstract] [Full Text] [Related]
8. Deficiency of steroid beta-glucosidase in Gaucher disease.
Kanfer JN; Raghavan SS; Mumford RA; Labow RS; Williamson DG; Layne DS
Biochem Biophys Res Commun; 1975 Nov; 67(2):683-8. PubMed ID: 1201047
[No Abstract] [Full Text] [Related]
9. Lysosomal storage diseases.
Glew RH; Basu A; Prence EM; Remaley AT
Lab Invest; 1985 Sep; 53(3):250-69. PubMed ID: 2993742
[No Abstract] [Full Text] [Related]
10. The liver in lipid storage disease: biochemical basis of pathogenesis and clinical features.
Brady RO; James SP; Barranger JA
Prog Liver Dis; 1982; 7():331-46. PubMed ID: 6810410
[No Abstract] [Full Text] [Related]
11. Sphingolipid metabolism in neural tissues.
Brady RO
Neurosci Res (N Y); 1969; 2(0):301-15. PubMed ID: 4950732
[No Abstract] [Full Text] [Related]
12. [Procedure for the diagnosis of sphingolipidoses or allied diseases in adult patients with neurological or psychiatric symptoms (author's transl)].
Pilz H; Heipertz R; Seidel D
Nervenarzt; 1979 Dec; 50(12):749-61. PubMed ID: 94938
[No Abstract] [Full Text] [Related]
13. Enzymic diagnosis of sphingolipidoses.
Suzuki K
Methods Enzymol; 1978; 50():456-88. PubMed ID: 26837
[No Abstract] [Full Text] [Related]
14. Fibroblast phosphodiesterase deficiency in Niemann-Pick disease.
Fensom AH; Benson PF; Babarik AW; Grant AR; Jacobs L
Biochem Biophys Res Commun; 1977 Feb; 74(3):877-83. PubMed ID: 191016
[No Abstract] [Full Text] [Related]
15. Heritable catabolic and anabolic disorders of lipid metabolism.
Brady RO
Metabolism; 1977 Mar; 26(3):329-45. PubMed ID: 13262
[TBL] [Abstract][Full Text] [Related]
16. Inherited lipid storage diseases of the central nervous system.
Percy AK; Shapiro LJ; Kaback MM
Curr Probl Pediatr; 1979 Sep; 9(11):1-51. PubMed ID: 117977
[No Abstract] [Full Text] [Related]
17. Diagnosis of the sphingolipidoses with labelled natural substrates.
Svennerholm L
Adv Exp Med Biol; 1978; 101():689-706. PubMed ID: 96667
[TBL] [Abstract][Full Text] [Related]
18. Basic findings and current developments in sphingolipidoses.
Pilz H; Heipertz R; Seidel D
Hum Genet; 1979 Mar; 47(2):113-34. PubMed ID: 108196
[TBL] [Abstract][Full Text] [Related]
19. Concentrations of an activator protein for sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseases.
Inui K; Wenger DA
J Clin Invest; 1983 Nov; 72(5):1622-8. PubMed ID: 6415115
[TBL] [Abstract][Full Text] [Related]
20. An enzymological approach to the lipidoses.
Tallman JF; Pentchev PG; Brady RO
Enzyme; 1974; 18(1):136-49. PubMed ID: 4211795
[No Abstract] [Full Text] [Related]
[Next] [New Search]
